WPI 844 (Glipizide Extended Release 5 mg)

Pill with imprint WPI 844 is Orange, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 844

Glipizide Extended Release

Imprint:

WPI 844

Strength:

5 mg

Color:

Orange

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Sulfonylureas

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Watson Laboratories, Inc.

Inactive Ingredients:

• acetyltributyl citrate
• ammonia
• butyl alcohol
• ferrosoferric oxide
• hydroxyethyl cellulose (2000 cps at 1%)
• isopropyl alcohol
• lactose monohydrate
• magnesium stearate
• methacrylic acid - methyl methacrylate copolymer (1:1)
• polyethylene glycol 400
• propylene glycol
• shellac
• FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00591-0844	Watson Pharmaceuticals, Inc.
68084-0111	Amerisource Health Services
10370-0190	Anchen Pharmaceuticals, Inc.
54569-5547	A-S Medication Solutions, LLC (repackager)
54868-5210	Physicians Total Care Inc. (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer